Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.

Por Neelke C van der Weerd, Muriel P C Grooteman, Michiel L Bots, Marinus A van den Dorpel, Claire H den Hoedt, Albert H A Mazairac, Menso J Nubé, E Lars Penne, Carlo A Gaillard, Jack F M Wetzels, Erwin T Wiegerinck, Dorine W Swinkels, Peter J Blankestijn, Piet M Ter Wee, CONTRAST Investigators
Publicado em 2012-01-01